SOCS3 and chronic myelogenous leukemia, BCR-ABL1 positive: We found that SOCS3 expression was down-regulated in human leukemia cells, with the lowest expression levels in K562 cells, indicating that SOCS3 could be down-regulated in CML (Fig. 1a).